Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Digestion|August 7, 2004
Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitisHiroyuki Hanai, Fumitoshi Watanabe, Masami Yamada, et al.
Radiation Protection Dosimetry|September 9, 2022
DEVELOPMENT OF A ROBOT FOR THE MEASUREMENT OF RADIOACTIVE CONTAMINATION AND FERTILITY OF THE SOIL IN FARMLANDMinoru Tanigaki, Yoshio Inoue, Sadao Momota, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot studyHiroyuki Hanai, Fumitoshi Watanabe, Ken Takeuchi, et al.
Clinical Pharmacology and Therapeutics|October 19, 2002
Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazoleTakahisa Furuta, Naohito Shirai, Fumitoshi Watanabe, et al.
Inflammatory Bowel Diseases|January 6, 2010
Thiopurine maintenance therapy for ulcerative colitis: the clinical significance of monitoring 6-thioguanine nucleotideHiroyuki Hanai, Takayuki Iida, Ken Takeuchi, et al.
World Journal of Gastroenterology|May 31, 2006
Effects of adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with active ulcerative colitisHiroyuki Hanai, Takayuki Iida, Masami Yamada, et al.
Plos One|July 9, 2021
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel diseaseMasaichi Kato, Ken Sugimoto, Kentaro Ikeya, et al.
Journal of Cancer Research and Clinical Oncology|July 24, 2002
Expression profile of EFNB1, EFNB2, two ligands of EPHB2 in human gastric cancerHideki Kataoka, Masamitsu Tanaka, Masao Kanamori, et al.
Journal of Clinical Apheresis|May 14, 2005
Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?Abbi R Saniabadi, Hiroyuki Hanai, Yasuo Suzuki, et al.
Journal of Crohn'S & Colitis|May 16, 2020
Highly Bioavailable Curcumin Derivative Ameliorates Crohn's Disease Symptoms: A Randomized, Double-Blind, Multicenter StudyKen Sugimoto, Kentaro Ikeya, Shigeki Bamba, et al.
Pageof 7